Cardiovascular risk factors in type 2 diabetic patients: Multifactorial intervention in primary care

Kidney International, Supplement

Volumn 67, Issue 93, 2005, Pages

  Tranche, Salvador ^a   Galgo, Alberto ^b   Mundet, Xavier ^b   Sanchez Zamorano, Miguel Angel ^b  

^a Centro de Salud El Cristo   (Spain)

^b NONE

Author keywords

Cardiovascular risk; Multifactorial intervention; Type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT; STATINE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN;

ADULT; AGED; BEHAVIOR MODIFICATION; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CLINICAL TRIAL; CONFERENCE PAPER; DYSLIPIDEMIA; FEMALE; FOLLOW UP; GENDER; HEMOGLOBIN DETERMINATION; HUMAN; HYPERTENSION; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIMARY MEDICAL CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY PREVENTION; SMOKING CESSATION; CONTROLLED STUDY; DIABETIC PATIENT; ARTICLE; HYPERGLYCEMIA; HYPERLIPIDEMIA; MIDDLE AGED; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; RISK FACTOR; SMOKING;

AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED; OBESITY; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 10944256579     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.09313.x     Document Type: Conference Paper

References (36)

1. STAMLER J, VACCARO O, NEATON JD, WENTWORTH D: Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16:434, 1993
2. STERN MP: Glycaemia and cardiovascular risk. Diabetes Care 20: 1501-1502, 1997
3. TURNER RC, MILLINS H, NEIL HA, et al: Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus. United Kingdom Diabetes Study (UKPDS 23). BMJ 316:823-828, 1998
4. YUDKIN JS: How can we best prolong life? Benefits of coronary risk factor reduction in non-diabetic and diabetic subjects. BMJ 306:1313, 1993
5. ZANCHETTI A, RUILOPE LM: Antihypertensive treatment in patients with type 2 diabetes mellitus: What guidance from recent controlled randomized trials? J Hypertens 20:2099-2110, 2002
6. MRC/BHF HEART PROTECTION STUDY OF CHOLESTEROL LOWERING WITH SIMVASTATIN IN 20.536 HIGH-RISK INDIVIDUALS: A randomised placebo-controlled trial. Lancet 360:7-22, 2002
7. GAEDE P, VEDEL P, LARSEN N, et al: Multifactor intervention and cardiovascular disease in patients with tipe 2 diabetes. N Engl J Med 348: 383-393, 2003
8. D'AGOSTINO RB, SR., GRUNDY S, SULLIVAN LM, WILSON P: Validation of the Framingham coronary heart disease prediction scores: Results of a multiple ethnic groups investigation. JAMA 286: I80-187, 2001
9. MARRUGAT J, D'ACOSXINO R, SULLIVAN L, et al: An adaptation of the Framingham coronary risk function to European Mediterranean areas. J Epidemiol Community Health 57: 634-638, 2003
10. BOUMA M, DEKKER JH, VAN EUK JTHM, et al: Metabolic control and morbidity of type 2 diabetic patients in a general practice network. Family Practice 16: 402-106, 1999
11. FERNÁNDEZ DE MENDIOLA J, IZA A, LASA I, et al: Evaluación de la población diabética tipo 2 atendida en un equipo de atencion primaria. Atención Primaria 17: 435-138, 1996
12. CLARK CM, SNYDER JW, MEEK RL, et al: A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 24: 1079-1086, 2001
13. NELSON KM, REIBER GR, BOYKO EJ: Diet and exercise among adults with type 2 diabetes. Diabetes Care 25: 1722-1728, 2002
14. WILKES S, EVANS A: A cross-sectional study comparing the motivation for smoking cessation in apparently healthy patients who smoke and have ischemic heart disease, hypertension or diabetes. Family Practice 16: 608-610, 1999
15. CANGA N, IRALA J, VARA E, et al: Intervention study for smoking cessation in diabetic patients. Diabetes Care 23: 1455-1466, 2000
16. MAJUMDAR SR, GUIRGUIS LM, TOTH EL, et al: Controlled trial of a multifaceted intervention for improving quality of care for rural patients with type 2 diabetes. Diabetes Care 26: 3061-3066, 2003
17. MCFARLANE SI, JACOBER SJ, WINER N, et al: Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 25: 718-723, 2002
18. UKPDS: Tight blood pressure control and risk of macro vascular and micro vascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703, 1998
19. ADLER AI, STRATTON IM, NEIL HA, et al: Association of systolic blood pressure with macro vascular and micro vascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ 321: 412-119, 2000
20. COOPER M, JOHNSTON CI: Optimizing treatment of hypertension in patients with diabetes. JAMA 283: 3177-3179, 2000
21. 2003 EUROPEAN SOCIETY OF HYPERTENSION: European Society of Cardiology Guidelines for the management of Arterial Hypertension. J Hypertens 21: 1001-1053, 2003
22. BERLOWITZ DR, ASH AS, HICKEY EC, et al: Hypertension management in patients with diabetes. Diabetes Care 26: 255-359, 2003
23. AMERICAN DIABETES ASSOCIATION: Hypertension management in adults with diabetes. Diabetes Care 27 (Supp 1):S65-S67, 2004
24. FUNNEL MM, ANDERSON RM: The problem with compliance in diabetes. JAMA 284: 1709, 2000
25. KIRKMAN MS, WILLIAMS SR, CAFFREY HH, MARRERO DG: Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care 25: 1946-1951, 2002
26. OLIVARIUS NF, BECK-NIELSEN H, ANDREASEN AH, et al: Randomised controlled trial of structured personal care of type diabetes mellitus. BMJ 323: 1-9, 2001
27. RENDERS CM, VALK GD, FRANSE LV, et al: Long-term effectiveness of a quality improvement program for patients with type 2 diabetes in general practice. Diabetes Care 24: 1365-1370, 2001
28. MASSING MW, FOLEY KA, SUETA CA, et al: Trends in lipid management among patients with coronary artery disease. Diabetes Care 26: 991-997, 2003
29. SHEPHERD J, BLAUW GJ, MURPHY MB, et al: Pravastatin in elderly individuals at risk of vascular disease (PROSPER). A randomised controlled trial. Lancet 360: 1623-1630, 2002
30. PYORALA K, PEDERSEN TR, KJEKSHUS J, et al: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S). Diabetes Care 20: 614-620, 1997
31. PHILLIPS LS, BRANCH WT, COOK CB, et al: Clinical inertia. Ann Intern Med 135: 825-834, 2001
32. BERLOWITZ DR, ASH AS, HICKEY EC, et al: Inadequate management of blood pressure in a hypertensive population. N Eng J Med 339: 1957-1963, 1998
33. EL-KEBBI IM, ZIEMER DC, MUSEY VC, et al: Diabetes in urban African-Americans. IX. Provider adherence to management protocols. Diabetes Care 20: 698-703, 1997
34. AMERICAN DIABETES ASSOCIATION: Aspirin therapy in diabetes. Diabetes Care 27(Supp 1):s72-s73, 2004
35. ESMATJES E, CASTELL C, FRANCH J, et al: Consumo de ácido acetilsalicílico en pacientes con diabetes mellitus. Med Clin (Barc) 122: 96-98, 2004
36. KREIN SL, VIJAN S, POGACH L, et al: Aspirin use and counselling about aspirin among patients with diabetes. Diabetes Care 25: 965-970, 2002